Effective December 1, 2020, Christopher Mulvanny, a principal shareholder of JNC Medical Inc., completed the sale of his stake in the company to 9888055 Canada Inc. and another individual.

JNC Medical Inc., headquartered in Ottawa, is a distribution consulting firm specializing in facilitating access to innovative medical device technologies and solutions.

Lorraine Mastersmith and Martin Roy of Gowling WLG advised Mr. Mulvanny in this transaction.